Monopar Therapeutics

MNPR

Monopar Therapeutics has been a target of short sellers for a while. The current short interest of 12.70% is slightly below the average of the last 12 months (16.96%).

Short Interest Trend

Share Price

Total NSP

12.70%

-0.52%

vs. last month

Also interesting? All insider buys at Monopar Therapeutics

Found an error? Questions? Ideas?